Live Combined Bifidobacterium,Lactobacillus And Enterococcus Capsules
Nervous System Disorder
Beijing Friendship HospitalUNKNOWNPhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 89/ 100
Competitive context
30 Active assets in the Nervous System Disorder cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Ginkgolide Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 4 | BB |
Guanfacine Maimonides Medical Center | Phase 4 | BB |
Brexpiprazole Otsuka Pharmaceutical Development & Commercialization, Inc. | Phase 3 | BB |
3-N-BUTYLPHTHALIDE Qianfoshan Hospital | Phase 4 | BB |
D-Thioctic Acid Ain Shams University | Phase 4 | BB |
View all 50 →
Same molecule, other indications
Live Combined Bifidobacterium,Lactobacillus And Enterococcus Capsules is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →